At least, two studies showed that higher CD164 mRNA expression in patients with lung adenocarcinoma and squamous cell lung cancer might significantly correlate with worse overall survival (HR =2.13; HR =1.68) in the five Kaplan-Meier survival curves from PRECOG database [32, 33]. This evidence concerns the gene CD164 and lung adenocarcinoma.